SCHEMBL13879458

SCHEMBL13879458

COc1ccccc1N1C(=O)C2Cc3ccccc3CN2C1=O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.70
HTT P42858 2/20 0.70
TSHR P16473 1/20 0.66
GAA P10253 3/20 0.60
KDM4E B2RXH2 1/20 0.60
USP2 O75604 1/20 0.60
POLB P06746 1/20 0.60
THRB P10828 1/20 0.60
RECQL P46063 1/20 0.60
HSD17B10 Q99714 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
RAB9A P51151 1/20 0.60
GRM4 Q14833 1/20 0.48
ADORA2A P29274 1/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.48
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
SIGMAR1 Q99720 3/20 0.46
CASP3 P42574 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14547045 0.80 ALDH1A1 (0.71) ALDH1A1HTTTSHRGAARAB9A
SCHEMBL13879410 0.80 KDM4E (0.57) ALDH1A1HTTGAAKDM4EUSP2
SCHEMBL13879490 0.80 TSHR (1.00) ALDH1A1HTTTSHRPOLBRAB9A
SCHEMBL13879455 0.79 KDM4E (0.56) ALDH1A1HTTGAAKDM4EUSP2
SCHEMBL13879404 0.78 TSHR (0.78) ALDH1A1HTTTSHRGAAUSP2
SCHEMBL13879415 0.76 RAB9A (0.79) ALDH1A1HTTTSHRGAARAB9A
SCHEMBL13879530 0.72 RAB9A (0.76) ALDH1A1HTTTSHRRAB9AGRM4
SCHEMBL6769384 0.72 RAB9A (0.67) ALDH1A1HTTTSHRGAAHSD17B10
SCHEMBL6769387 0.72 RAB9A (0.67) ALDH1A1HTTTSHRGAAHSD17B10
SCHEMBL23657643 0.72 RAB9A (0.74) ALDH1A1HTTTSHRGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099186-A1 INHIBITORS OF VIRAL REPLICATION INTERMUNE, INC. 2009-04-16 US disclosed
US-20090099186-A1 INHIBITORS OF VIRAL REPLICATION INTERMUNE, INC. 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099186-A1 INHIBITORS OF VIRAL REPLICATION EIF2AK2, HAVCR2, RTF2 ALDH1A1 1500/4885HTT 4261/4885TSHR 4851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.